"Lizard" <lizardpriest@[EMAIL PROTECTED]
> wrote:
>> Proof is one thing, but it's pretty clear that heavy third- and
>> fourth-plateau users (people taking such doses more than once or twice
>> a week) can develop NMDA-antagonist neurotoxicity. However, it may or
>> may not be the largest concern - addiction itself would probably be
>> the bigger issue to worry about.
>
>It is not clear at all. There isn't even any convincing anecdotal
>evidence of it. It simply does not happen, and has NEVER happened to
>anybody, as far as can be determined by any scientific method, and
>there have been 3 clinical studies (one in the US, one in the
>Netherlands and one in France. I am looking for the abstracts and
>will post them as soon as I find them) that looked for such evidence
>and found none.
It's not enough to say it hasn't been proven, and it's wrong to say
that there isn't any convincing anecdotal evidence. Some people
really get addicted to high-plateau DXM trips, and show signs of
damage that would be consistent with NAN. It's not the most im****tant
issue, I think, but it's certainly a relevant one.
>Now, if what you are talking about is S*****onin Syndrome (a different
>thing altogether) you are on firmer ground. While rare, and almost
>always as a side effect of mixing SSRI's with very high doses of DXM,
>it has been recorded. S*****onin Syndrome is tem****ary (if it doesn't
>kill you, that is) and does not cause degenerative damage.
I'm not sure why you considered that related to anything I said.
--
Joel Crump
|
